Physician Assistant · Miami, FL
NPI
1467854208
Since 2014
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
11801 SW 90th St, Suite 201
Miami, FL, 33186
Phone (305) 595-1317
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,549
73 services
Medicare patients, 2024
56
Average age 60
Drug cost, 2024
$4.6M
2,646 prescriptions
Company payments, 2023
$41.57
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Simon E Valladares was code 99214 (office e&m - established), 61 times for 49 patients. In total Simon E Valladares billed 73 services in 5 codes, and Medicare paid $4,549.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 61 | 49 | $65.50 | $3,995 |
By year: 2022 $32K for 705 services; 2023 $10K for 164 services; 2024 $4,549 for 73 services.
Medicare prescription drug claims, 2024
In 2024, the drug Simon E Valladares prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 345 prescriptions and refills. In total Simon E Valladares wrote 2,646 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 345 | 345 | 73 | $1.4M |
| Tivicay Dolutegravir Sodium | 183 | 183 | 32 | $454K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 167 | 167 | 26 | $661K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 126 | 126 | 21 | $466K |
| Rosuvastatin Calcium Generic | 110 | 190 | 36 | $1,310 |
| Amlodipine Besylate Generic | 108 | 187 | 35 | $437 |
| Descovy Emtricitabine/Tenofov Alafenam | 93 | 93 | 18 | $209K |
| Lisinopril Generic | 93 | 148 | 36 | $350 |
| Juluca Dolutegravir/Rilpivirine | 85 | 85 | 16 | $295K |
| Hydrochlorothiazide Generic | 80 | 120 | 21 | $135 |
| Atorvastatin Calcium Generic | 77 | 139 | 27 | $347 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 69 | 79 | 17 | $360K |
| Prezcobix Darunavir/Cobicistat | 68 | 68 | Under 11 | $176K |
| Gabapentin Generic | 50 | 50 | 14 | $470 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 48 | 54 | Under 11 | $68K |
Brand drugs: 1,377 claims; generic drugs: 1,242 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Simon E Valladares $41.57 ($41.57 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $41.57.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 2 | $41.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.